Response of human amnion cells in culture to 1,25-dihydroxycholecalciferol: Increased 25-hydroxycholecalciferol 24-hydroxylase activity and prostaglandin E2 formation

M. Linette Casey, Jim Griffin III, Klaus Korte, Murray D. Mitchell, Paul C. MacDonald

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We investigated the possibility that 1,25-dihydroxycholecalciferol acts in human amnion as a physiologic calcium ionophore to effect increased prostaglandin E2 production in this tissue. This possibility was based on the propositions that (1) this metabolite of vitamin D3 acts in other target tissues, that is, bone, intestine, chorioallantoic membrane, kidney, and intestine, to effect increased calcium absorption, (2) that 1,25-dihydroxycholecalciferol is present in amniotic fluid, which bathes the amnion, and (3) that the mobilization of calcium in amnion is associated with stimulation of enzymes, namely, phospholipase A2 and phosphatidylinositol-specific phospholipase C that act ultimately to effect the release of arachidonic acid, which in turn leads to increased prostaglandin E2 production. We found that human amnion cells, maintained in primary monolayer culture, are responsive to 1,25-dihydroxycholecalciferol. Treatment of these cells with 1,25-dihydroxycholecalciferol for 18 hours brought about the induction, in a dose-dependent manner, of 25-hydroxycholecalciferol 24-hydroxylase, a marker of 1,25-dihydroxycholecalciferol action. In addition, treatment of human amnion cells in monolayer culture with 1,25-dihydroxycholecalciferol caused, within 12 hours, a significant increase in the synthesis of prostaglandin E2, which was maintained for the duration of treatment, that is, 48 hours. These findings may be indicative of a significant physiologic role for 1,25-dihydroxycholecalciferol in metabolic processes that are important in amnion, including transport, amniotic fluid volume homeostasis, and the initiation of parturition.

Original languageEnglish (US)
Pages (from-to)1272-1275
Number of pages4
JournalAmerican Journal of Obstetrics and Gynecology
Volume155
Issue number6
DOIs
StatePublished - Jan 1 1986

Fingerprint

Amnion
Calcitriol
Dinoprostone
Cell Culture Techniques
Amniotic Fluid
Intestines
Calcium
Phosphoinositide Phospholipase C
Chorioallantoic Membrane
Calcium Ionophores
Cholecalciferol
Phospholipases A2
Vitamin D3 24-Hydroxylase
Arachidonic Acid
Homeostasis
Parturition
Kidney
Bone and Bones
Enzymes

Keywords

  • 1
  • 25-Dihydroxycholecalciferol
  • amnion
  • calcium
  • prostaglandin E

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Response of human amnion cells in culture to 1,25-dihydroxycholecalciferol : Increased 25-hydroxycholecalciferol 24-hydroxylase activity and prostaglandin E2 formation. / Casey, M. Linette; Griffin III, Jim; Korte, Klaus; Mitchell, Murray D.; MacDonald, Paul C.

In: American Journal of Obstetrics and Gynecology, Vol. 155, No. 6, 01.01.1986, p. 1272-1275.

Research output: Contribution to journalArticle

@article{87c9ba6cc2c949678d96d0e7f6f631cb,
title = "Response of human amnion cells in culture to 1,25-dihydroxycholecalciferol: Increased 25-hydroxycholecalciferol 24-hydroxylase activity and prostaglandin E2 formation",
abstract = "We investigated the possibility that 1,25-dihydroxycholecalciferol acts in human amnion as a physiologic calcium ionophore to effect increased prostaglandin E2 production in this tissue. This possibility was based on the propositions that (1) this metabolite of vitamin D3 acts in other target tissues, that is, bone, intestine, chorioallantoic membrane, kidney, and intestine, to effect increased calcium absorption, (2) that 1,25-dihydroxycholecalciferol is present in amniotic fluid, which bathes the amnion, and (3) that the mobilization of calcium in amnion is associated with stimulation of enzymes, namely, phospholipase A2 and phosphatidylinositol-specific phospholipase C that act ultimately to effect the release of arachidonic acid, which in turn leads to increased prostaglandin E2 production. We found that human amnion cells, maintained in primary monolayer culture, are responsive to 1,25-dihydroxycholecalciferol. Treatment of these cells with 1,25-dihydroxycholecalciferol for 18 hours brought about the induction, in a dose-dependent manner, of 25-hydroxycholecalciferol 24-hydroxylase, a marker of 1,25-dihydroxycholecalciferol action. In addition, treatment of human amnion cells in monolayer culture with 1,25-dihydroxycholecalciferol caused, within 12 hours, a significant increase in the synthesis of prostaglandin E2, which was maintained for the duration of treatment, that is, 48 hours. These findings may be indicative of a significant physiologic role for 1,25-dihydroxycholecalciferol in metabolic processes that are important in amnion, including transport, amniotic fluid volume homeostasis, and the initiation of parturition.",
keywords = "1, 25-Dihydroxycholecalciferol, amnion, calcium, prostaglandin E",
author = "Casey, {M. Linette} and {Griffin III}, Jim and Klaus Korte and Mitchell, {Murray D.} and MacDonald, {Paul C.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0002-9378(86)90158-4",
language = "English (US)",
volume = "155",
pages = "1272--1275",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Response of human amnion cells in culture to 1,25-dihydroxycholecalciferol

T2 - Increased 25-hydroxycholecalciferol 24-hydroxylase activity and prostaglandin E2 formation

AU - Casey, M. Linette

AU - Griffin III, Jim

AU - Korte, Klaus

AU - Mitchell, Murray D.

AU - MacDonald, Paul C.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - We investigated the possibility that 1,25-dihydroxycholecalciferol acts in human amnion as a physiologic calcium ionophore to effect increased prostaglandin E2 production in this tissue. This possibility was based on the propositions that (1) this metabolite of vitamin D3 acts in other target tissues, that is, bone, intestine, chorioallantoic membrane, kidney, and intestine, to effect increased calcium absorption, (2) that 1,25-dihydroxycholecalciferol is present in amniotic fluid, which bathes the amnion, and (3) that the mobilization of calcium in amnion is associated with stimulation of enzymes, namely, phospholipase A2 and phosphatidylinositol-specific phospholipase C that act ultimately to effect the release of arachidonic acid, which in turn leads to increased prostaglandin E2 production. We found that human amnion cells, maintained in primary monolayer culture, are responsive to 1,25-dihydroxycholecalciferol. Treatment of these cells with 1,25-dihydroxycholecalciferol for 18 hours brought about the induction, in a dose-dependent manner, of 25-hydroxycholecalciferol 24-hydroxylase, a marker of 1,25-dihydroxycholecalciferol action. In addition, treatment of human amnion cells in monolayer culture with 1,25-dihydroxycholecalciferol caused, within 12 hours, a significant increase in the synthesis of prostaglandin E2, which was maintained for the duration of treatment, that is, 48 hours. These findings may be indicative of a significant physiologic role for 1,25-dihydroxycholecalciferol in metabolic processes that are important in amnion, including transport, amniotic fluid volume homeostasis, and the initiation of parturition.

AB - We investigated the possibility that 1,25-dihydroxycholecalciferol acts in human amnion as a physiologic calcium ionophore to effect increased prostaglandin E2 production in this tissue. This possibility was based on the propositions that (1) this metabolite of vitamin D3 acts in other target tissues, that is, bone, intestine, chorioallantoic membrane, kidney, and intestine, to effect increased calcium absorption, (2) that 1,25-dihydroxycholecalciferol is present in amniotic fluid, which bathes the amnion, and (3) that the mobilization of calcium in amnion is associated with stimulation of enzymes, namely, phospholipase A2 and phosphatidylinositol-specific phospholipase C that act ultimately to effect the release of arachidonic acid, which in turn leads to increased prostaglandin E2 production. We found that human amnion cells, maintained in primary monolayer culture, are responsive to 1,25-dihydroxycholecalciferol. Treatment of these cells with 1,25-dihydroxycholecalciferol for 18 hours brought about the induction, in a dose-dependent manner, of 25-hydroxycholecalciferol 24-hydroxylase, a marker of 1,25-dihydroxycholecalciferol action. In addition, treatment of human amnion cells in monolayer culture with 1,25-dihydroxycholecalciferol caused, within 12 hours, a significant increase in the synthesis of prostaglandin E2, which was maintained for the duration of treatment, that is, 48 hours. These findings may be indicative of a significant physiologic role for 1,25-dihydroxycholecalciferol in metabolic processes that are important in amnion, including transport, amniotic fluid volume homeostasis, and the initiation of parturition.

KW - 1

KW - 25-Dihydroxycholecalciferol

KW - amnion

KW - calcium

KW - prostaglandin E

UR - http://www.scopus.com/inward/record.url?scp=0023038697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023038697&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(86)90158-4

DO - 10.1016/0002-9378(86)90158-4

M3 - Article

C2 - 3466544

AN - SCOPUS:0023038697

VL - 155

SP - 1272

EP - 1275

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -